This trial has been completed.

Conditions hemophilia a, hemophilia b, factor viii deficiency, factor ix deficiency
Treatment accelerometer
Sponsor The Hospital for Sick Children
Collaborator Canadian Hemophilia Society
Start date September 2013
End date July 2014
Trial size 66 participants
Trial identifier NCT02199717, 1000039947


This pilot project was developed to investigate subjective and objective data related to the patterns of physical activity participation among hemophilia patients (FVIII or FIX) between the ages of 5 and 18 years. Physical activity participation among different levels of disease severity will be compared using accelerometers to calculate the amount of time spent in moderate to vigorous physical activity (MVPA) and the number of bouts of MVPA; additionally, data will be collected from two validated questionnaires (PedHAL and 3 day physical activity recall). Current literature that relates level of physical activity to disease severity in the pediatric hemophilia population is limited. The information gained about the type and quantity of physical activity participation in children with varying levels of hemophilia will assist in the development of education and interventions to promote good physical activity and potentially examine the role of tailored prophylaxis.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Accelerometer use for 1 week.
accelerometer ActiLife

Primary Outcomes

time frame: 7 days
Sedentary Time
time frame: 7 days

Eligibility Criteria

Male participants from 5 years up to 17 years old.

Inclusion Criteria: - 5-17 years of age, has a diagnosis of Hemophilia A or B. Exclusion Criteria: - Muscle or joint bleed within 4 weeks of study. - Pre-existing co-morbidities that would affect physical activity participation. - Unable to cooperate with study protocol. - Unable to speak, read, or understand English.

Additional Information

Official title An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia
Principal investigator Vanessa Bouskill, NP, MN
Description Objectives: 1. To determine if the amount of time spent performing moderate to vigorous physical activity (MVPA) and the number of bouts of MVPA engaged in on a weekly basis differs by the level of disease severity in the pediatric hemophilia population. 2. To determine if recorded physical activities and intensity of activities from self-report questionnaires (PedHAL and 3 day physical activity recall - 3DPAR) differ according to the severity of hemophilia. 3. To determine if, among patients with hemophilia, there is a relationship between physical activity level and patient age, weight, and body mass index (BMI). Specific Aims: •Aim # 1: The primary aim of the study is to determine if there are differences in the amount of time spent in MVPA by level of disease severity of children with hemophilia. Secondary Aims: - Aim # 2: To determine if there are meaningful differences in the accumulation of MVPA (bouts of exercise) by disease severity of children with hemophilia. - Aim # 3: The compare the findings from Aim #1 and #2 to the NHANES (National Health and Nutrition Examination Survey) data, recognizing that this survey provides a comparative healthy normal cohort. - Aim # 4: To investigate MVPA with these data collected from the PedHAL (11) and the 3DPAR (12) by disease severity of children with hemophilia. - Aim # 5: The review and determine the relationship between physical activity participation and timing of prophylaxis factor replacement and whether participation is limited to days of factor infusion. - Aim #6: To investigate the amount of physical activity and how it relates to age, weight, and patient body mass index (BMI).
Trial information was received from ClinicalTrials.gov and was last updated in December 2016.
Information provided to ClinicalTrials.gov by The Hospital for Sick Children.